On Tuesday, HCA Healthcare Inc (NYSE: HCA) opened higher 0.36% from the last session, before settling in for the closing price of $303.52. Price fluctuations for HCA have ranged from $268.80 to $417.14 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 6.95%. Company’s average yearly earnings per share was noted 15.48% at the time writing. With a float of $181.00 million, this company’s outstanding shares have now reached $254.52 million.
The extent of productivity of a business whose workforce counts for 310000 workers is very important to gauge. In terms of profitability, gross margin is 50.04%, operating margin of 15.08%, and the pretax margin is 12.55%.
HCA Healthcare Inc (HCA) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Medical Care Facilities industry is another important factor to consider. The insider ownership of HCA Healthcare Inc is 28.54%, while institutional ownership is 64.04%. The most recent insider transaction that took place on Nov 14 ’24, was worth 527,677. In this transaction SVP & Chief Ethics Officer of this company sold 1,474 shares at a rate of $357.99, taking the stock ownership to the 9,454 shares. Before that another transaction happened on Nov 14 ’24, when Company’s SVP-Internal Audit Services sold 3,897 for $350.00, making the entire transaction worth $1,363,950. This insider now owns 52,702 shares in total.
HCA Healthcare Inc (HCA) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 15.48% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.00% during the next five years compared to 12.21% growth over the previous five years of trading.
HCA Healthcare Inc (NYSE: HCA) Trading Performance Indicators
Check out the current performance indicators for HCA Healthcare Inc (HCA). In the past quarter, the stock posted a quick ratio of 1.00. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.11. Likewise, its price to free cash flow for the trailing twelve months is 13.12.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 22.28, a number that is poised to hit 6.14 in the next quarter and is forecasted to reach 24.60 in one year’s time.
Technical Analysis of HCA Healthcare Inc (HCA)
The latest stats from [HCA Healthcare Inc, HCA] show that its last 5-days average volume of 1.52 million was superior to 1.21 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 32.58%. Additionally, its Average True Range was 7.28.
During the past 100 days, HCA Healthcare Inc’s (HCA) raw stochastic average was set at 6.62%, which indicates a significant decrease from 27.63% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 16.66% in the past 14 days, which was lower than the 25.06% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $344.84, while its 200-day Moving Average is $346.61. Now, the first resistance to watch is $305.60. This is followed by the second major resistance level at $306.58. The third major resistance level sits at $308.54. If the price goes on to break the first support level at $302.66, it is likely to go to the next support level at $300.70. The third support level lies at $299.72 if the price breaches the second support level.
HCA Healthcare Inc (NYSE: HCA) Key Stats
There are currently 253,297K shares outstanding in the company with a market cap of 77.16 billion. Presently, the company’s annual sales total 64,968 M according to its annual income of 5,242 M. Last quarter, the company’s sales amounted to 17,487 M and its income totaled 1,270 M.
